Rensselaer Polytechnic Institute

The Benchmark Company Expands its Technology M&A Focus with Leadership Hires

Retrieved on: 
Thursday, October 12, 2023
Benchmark, Cloud, Data infrastructure, Mobility, Corporation, Investment banking, TMT, William Blair & Company, University, Digital media, Lehman Brothers, Rensselaer Polytechnic Institute, Enterprise, AudioCodes, Amherst College, Growth, Cornell University, United Nations Technology Bank for Least Developed Countries, Customer engagement, Cloud communications, M.E, Research, Cryptocurrency, Financial services, Computer security, Telecom

Derek Wittenberg and Dmitry Netis , both Managing Directors, Investment Banking, are establishing and leading the firm’s Technology, Media, and Telecom (TMT) M&A vertical.

Key Points: 
  • Derek Wittenberg and Dmitry Netis , both Managing Directors, Investment Banking, are establishing and leading the firm’s Technology, Media, and Telecom (TMT) M&A vertical.
  • "Technology is reshaping all of our clients' industries and represents a significant opportunity for their differentiation and growth.
  • “We are excited to join the Benchmark banking team to strengthen the firm’s investment banking focus in this important sector.
  • We look forward to Derek and Dmitry’s contributions to our deep bench of banking and advisory professionals,” added Richard Messina.

Fundamentals of The Texas ERCOT Electric Power Market: Register Now for the 2 Day Industry Seminar (Houston, United States - December 7-8, 2023) - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 12, 2023
Utilities, Energy, Energy demand management, Erongo Battery Energy Storage System, Knowledge, DER, Transmission, Bayes Business School, ERCOT, MS, LMP, Valuation, Rensselaer Polytechnic Institute, Electricity, Natural gas, Battery, International Renewable Energy Agency, DSM, ISO, Doctor of Philosophy, World Bank, Gas, LTSA, Public policy, IRP, Non-wires alternatives, Power engineering, Ancillary services (electric power), Distributed generation, Electric power, Renewable energy, Cryptocurrency, Auction, Electric battery, Economics, Wind

The "Fundamentals of The Texas ERCOT Electric Power Market" training has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Fundamentals of The Texas ERCOT Electric Power Market" training has been added to ResearchAndMarkets.com's offering.
  • Gain an understanding of the dynamic Texas wholesale and retail competitive markets, and learn how these markets interface with ERCOT ISO energy auctions and ISO operations.
  • Understand, enhance and apply knowledge of the ERCOT' nodal market operations for Energy, Ancillary Services, Market Settlements, Capacity, Retail and Renewables.
  • The key wholesale and retail stakeholders and market participants are, and how their activities shape ERCOT's operations.

Mount Sinai Launches Discovery and Innovation Center in Midtown West

Retrieved on: 
Friday, October 6, 2023
Human Genome Sciences, Personalized medicine, Engineering, Rensselaer Polytechnic Institute, Environment, Research, Bernard, Orthopedic surgery, Mount Sinai Health System, DNA, Proteomics, DVM, Stem cell, Health, Neuroscience, MTR, Icahn School of Medicine at Mount Sinai, Metabolomics, Biotechnology, Medicine, Genomics, Dermatology, The Center, Investment, Partnership, Innovation Center station, Doctor of Philosophy, New Center, Detroit, Eleventh Avenue, Microscopy, Icahn, Therapy, Discovery, Laboratory, FAAD, Immunology, Science, Sensation, Neuroinflammation, Patient, Pharmaceutical industry, Hospital, Mount Sinai West, Innovation, MD, Genetics

NEW YORK, Oct. 6, 2023 /PRNewswire-PRWeb/ -- New Center to Expand Research Capabilities and Bring Leading Researchers in Health Care, Innovation, and Basic Science Together at Mount Sinai West Campus.

Key Points: 
  • Today, the Mount Sinai Health System, New York City's largest academic medical system, announced the opening of its new Discovery and Innovation Center with a ceremonial ribbon cutting.
  • But it will also foster unprecedented collaboration among world-class researchers at Icahn Mount Sinai and their clinical counterparts at Mount Sinai West."
  • "Mount Sinai West, which is situated close to the new Discovery and Innovation Center, has one of the best clinical neuroscience centers in the world.
  • "The opportunity to work in close collaboration with the researchers at the Discovery and Innovation Center will open up new possibilities both here on the West Side and in the fields of science and medicine," said Evan L. Flatow, MD, President of Mount Sinai West and Mount Sinai Morningside, and the Bernard J. Lasker Professor of Orthopaedics at Icahn Mount Sinai.

Slone Partners Places Cynthia Pussinen as Chief Executive Officer and Member of the Board of Directors at Sernova Corporation

Retrieved on: 
Thursday, September 14, 2023
Sequence, Actinium, University, United Board for Christian Higher Education in Asia, Change, Bachelor of Science in Human Biology, Drug development, Therapy, Spark, Master of Science in Respiratory Care, Health, Licensure, Research, Anidulafungin, Chemistry, Honeywell, Rensselaer Polytechnic Institute, Patient, Engineering, European, Roche, Management, Science, Ipsen

SOUTH RIDING, Va., Sept. 14, 2023 /PRNewswire-PRWeb/ -- Slone Partners, a nationwide executive search firm for life sciences, healthcare, and cybersecurity organizations, has announced the placement of Cynthia Pussinen as Chief Executive Officer (CEO) and a member of the Board of Directors at Sernova Corporation, a clinical-stage company and leader in cell therapeutics.

Key Points: 
  • SOUTH RIDING, Va., Sept. 14, 2023 /PRNewswire-PRWeb/ -- Slone Partners , a nationwide executive search firm for life sciences, healthcare, and cybersecurity organizations, has announced the placement of Cynthia Pussinen as Chief Executive Officer (CEO) and a member of the Board of Directors at Sernova Corporation , a clinical-stage company and leader in cell therapeutics.
  • Pussinen's expertise spans the drug development continuum from research through commercialization.
  • Most recently, Pussinen served as Chief Technical Officer for Spark Therapeutics, Inc., a fully integrated, commercial gene therapy company, and a member of the Roche Group.
  • "She will make for a terrific addition to the Sernova leadership team and Board of Directors during a pivitol stage in the company's evolution."

Anokion Strengthens its Senior Leadership with Promotions and New Appointment

Retrieved on: 
Thursday, September 7, 2023
Biotechnology, Pharmaceutical, Health, Clinical Trials, Laboratory, Drug development, University, University of Hartford, Doctor of Philosophy, Abbott Laboratories, CMC, University of Florida, Immune tolerance, Pharmacokinetics, MBA, Research, Boston University, Chemistry, Shire, Acquisition, Novartis, Rensselaer Polytechnic Institute, AbbVie, Patient, Chemical engineering, Autoimmune disease, DMPK, Alexion, Growth, Merck Serono, Cadent, Therapy, Merrimack Pharmaceuticals, Microbiology, Management

Anokion SA , a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced a series of senior leadership promotions and a new senior appointment, effective immediately.

Key Points: 
  • Anokion SA , a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced a series of senior leadership promotions and a new senior appointment, effective immediately.
  • Kristie Grebe, Ph.D., has been promoted to chief scientific officer, Michael DiLeo has been promoted to senior vice president, corporate development and business operations and Nicole Luosey joins Anokion as senior vice president, product and development operations.
  • “We are pleased to announce these strategic leadership promotions and the expansion of our senior leadership team, all of which are a testament to the progress we have made advancing innovative solutions for autoimmune diseases,” said Deborah Geraghty, Ph.D., chief executive officer of Anokion.
  • Mike’s successful journey within Anokion, and deep contributions in corporate and business development, will continue to drive our growth and partnerships.

Sernova Corporation Announces the Appointment of Cynthia Pussinen as CEO

Retrieved on: 
Tuesday, September 5, 2023
Sequence, Actinium, University, United Board for Christian Higher Education in Asia, Bachelor of Science in Human Biology, Operation, Executive, Drug development, FSE, Therapy, Spark, Master of Science in Quality Management and Analytics, WEST, Health care, Licensure, PSH, Research, Anidulafungin, Type 1 diabetes, Chemistry, National Science Board, Honeywell, HBA, Rensselaer Polytechnic Institute, Patient, Engineering, European, TSX, Conditional sentence, Health, Woman, Pfizer, Roche, Management, Pharmaceutical industry, Nursing, Science, T1D, Ipsen

LONDON, Ontario and WINDHAM COUNTY, Conn., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced that its Board of Directors has appointed Cynthia Pussinen as Chief Executive Officer and a member of the Board of Directors. Dr. Philip Toleikis, who has led the company since 2009 as President and CEO will serve as Chief Technology Officer.

Key Points: 
  • Dr. Philip Toleikis, who has led the company since 2009 as President and CEO will serve as Chief Technology Officer.
  • Most recently, Ms. Pussinen was the Chief Technical Officer for Spark Therapeutics, Inc., a fully integrated, commercial gene therapy company, and a member of the Roche Group.
  • I am very pleased to welcome Ms. Pussinen to the Sernova team as the new CEO and look forward to working together.
  • Sernova’s management will host investor calls, firstly to introduce Ms. Pussinen, and later, in approximately 30 days, to provide an overview of Sernova as well as a question-and-answer session.

Asurity® Technologies' CTO David Greenwood Honored as 2023 HousingWire Insider

Retrieved on: 
Friday, September 1, 2023
University College London, IBM, Housing, Doctor of Philosophy, Genworth Financial, Master of Science in Information Technology, Information technology, Engineering, PwC, Bystrup Architecture Design Engineering, Promontory, Rensselaer Polytechnic Institute, Promontory Financial Group, CIO, Management, Science, Architecture, Asure Software

WASHINGTON, Sept. 1, 2023 /PRNewswire/ -- Asurity Technologies, LLC ("Asurity"), a leader in the design and development of consumer lending compliance software, is proud to announce that David Greenwood, Ph.D., Chief Technology Officer (CTO), has been selected as a 2023 HousingWire Insider.

Key Points: 
  • WASHINGTON, Sept. 1, 2023 /PRNewswire/ -- Asurity Technologies, LLC ("Asurity"), a leader in the design and development of consumer lending compliance software, is proud to announce that David Greenwood, Ph.D., Chief Technology Officer (CTO), has been selected as a 2023 HousingWire Insider.
  • The HousingWire Insider award recipients were selected by HousingWire's selection committee based on their vital and dynamic contributions to their companies and the industry.
  • "I am deeply honored to be recognized as one of HousingWire's Insiders for 2023," said David Greenwood.
  • For more information on David Greenwood or Asurity, contact us at [email protected] or (202) 765-2150.

GE Vernova Announces Two Additions to Leadership Team

Retrieved on: 
Thursday, August 24, 2023
Finance, Consulting, Alternative Energy, Energy, Professional Services, AlliedSignal, WCC, Victor, Carrier Global, University, PwC, LM Wind Power, Vic, OC, Wind, Certified Public Accountant, CEO succession, United Technologies, Security, Wind power, Accounting, Rensselaer Polytechnic Institute, WESCO International, M.B.A, General Electric, UTC, Cooper, Renewable energy, Johnson Controls, Sea breeze, CFO, Union College, NYSE, American Wind Energy Association, Management

GE (NYSE: GE) announced today that GE Vernova has appointed two new leaders to its leadership team.

Key Points: 
  • GE (NYSE: GE) announced today that GE Vernova has appointed two new leaders to its leadership team.
  • These appointments complete the executive leadership team for GE Vernova as the business prepares to launch as an independent company sometime in early 2024.
  • “It’s a pleasure to welcome Ken to the GE Vernova leadership team as our Chief Financial Officer,” said Scott Strazik, CEO of GE Vernova.
  • We are fortunate that GE Vernova will continue to benefit from his demonstrated leadership and operational focus.”
    Click here to view the GE Vernova leadership team.

Peter Horowitz Joins BetaNXT as Head of Corporate Development

Retrieved on: 
Tuesday, August 15, 2023
American Industrial Partners, Bradstreet, Head, Statistics, Operations research, Dun, Albany Law School, Strategic planning, PwC, Dun & Bradstreet, Acquisition, Rensselaer Polytechnic Institute, BearingPoint, Corporation, Research, Corporate development, Management, Science

NEW YORK, Aug. 15, 2023 /PRNewswire/ -- BetaNXT, a provider of wealth management infrastructure software with real-time data capabilities and an enhanced advisor experience, announces that Peter Horowitz has joined the firm as Head of Corporate Development. In this position, he will build relationships with key stakeholders to help identify acquisition and joint venture opportunities while supporting BetaNXT's strategic planning processes to accelerate its mission and impact.

Key Points: 
  • NEW YORK, Aug. 15, 2023 /PRNewswire/ -- BetaNXT, a provider of wealth management infrastructure software with real-time data capabilities and an enhanced advisor experience, announces that Peter Horowitz has joined the firm as Head of Corporate Development.
  • "We welcome Peter to BetaNXT and look forward to collaborating with him to help us continue to grow and strengthen the wealth advisor experience."
  • Mr. Horowitz reports to Mr. Daffron and joins BetaNXT from Dun & Bradstreet, where he led corporate development and business strategy initiatives as Chief Strategy Officer.
  • "I have known the senior leadership at BetaNXT for some time, and I am proud to be working alongside them to further the company's mission and deliver more value to all stakeholders," said Peter Horowitz, Head of Corporate Development at BetaNXT.

Amtech Systems Announces CEO Transition

Retrieved on: 
Wednesday, August 9, 2023
Technology, Other Manufacturing, Semiconductor, Manufacturing, Acceleration, Rogers Corporation, University, Clean technology, EV, Engineering, Sustainability Accounting Standards Board, Electronics, Risk, System, Intelligence, COVID, Form 10-K, Silicon carbide, Rensselaer Polytechnic Institute, Investment, Nature, Form, Security (finance), Chemical engineering

To support the transition, Mr. Whang will remain as an advisor until February 8, 2024.

Key Points: 
  • To support the transition, Mr. Whang will remain as an advisor until February 8, 2024.
  • “I’d like to thank Michael for his service to Amtech over the past 19 years and for the last three years as Chief Executive Officer.
  • Our mission is to fully capitalize on these growth opportunities and deliver the profitability essential to creating shareholder value,” stated Bob Daigle, Chairman of the Board and CEO of Amtech Systems.
  • Mr. Daigle has served on the Amtech Board since August of 2021 and as Chairman of the Board since March of 2022.